Skip to main content
Top
Published in: Annals of Hematology 1/2019

01-01-2019 | Original Article

National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality

Authors: Ersi Voskaridou, Antonis Kattamis, Christina Fragodimitri, Alexandra Kourakli, Panagiota Chalkia, Michael Diamantidis, Efthymia Vlachaki, Marouso Drosou, Stilianos Lafioniatis, Konstantinos Maragkos, Fotini Petropoulou, Eftihios Eftihiadis, Marina Economou, Evangelos Klironomos, Freideriki Koutsouka, Konstantina Nestora, Ioanna Tzoumari, Ourania Papageorgiou, Artemis Basileiadi, Ioannis Lafiatis, Efthimia Dimitriadou, Anastasia Kalpaka, Chrysoula Kalkana, Georgios Xanthopoulidis, Ioannis Adamopoulos, Panagiotis Kaiafas, Aikaterini Mpitzioni, Anastasia Goula, Ioannis Kontonis, Chrisoula Alepi, Athanasios Anastasiadis, Margarita Papadopoulou, Polixeni Maili, Dionisia Dionisopoulou, Antigoni Tsirka, Alexandros Makis, Stavroula Kostaridou, Marianna Politou, Ioannis Papassotiriou, on behalf of the Greek Haemoglobinopathies Study Group

Published in: Annals of Hematology | Issue 1/2019

Login to get access

Abstract

National registries constitute an invaluable source of information and contribute to the improvement of hemoglobinopathy management. Herein, we present the second updated report of the National Registry for Haemoglobinopathies in Greece (NRHG) and critically discuss the time trends in demographics, affected births, and causes of mortality. Thirty-eight Greek hemoglobinopathy units reported data from diagnosis to the last follow-up or death by retrospectively completing an electronic form. Four thousand thirty-two patients were eligible for inclusion; more than half of them had thalassaemia major. Compared to the previous report, a reduction in the total number of all hemoglobinopathies except for hemoglobinopathy “Η” was evident. The total number of affected births was also reduced; most of them were attributable to diagnostic errors and lack of awareness. Importantly, data on iron overload are reported for the first time; although most patients had low or moderate liver iron concentration (LIC) values, a non-negligible proportion of patients had high LIC. The burden due to heart iron overload was less prominent. Cardiac- and liver-related complications are the major causes of morbidity and mortality. From 2000 to 2015, a decrease in heart-related deaths along with an increase in liver-associated fatalities was observed. The Hellenic Prevention Program along with advances in chelation regimens and iron status monitoring have resulted in improved patient outcomes. The NRHG gives insight into the effectiveness of prevention programs, the therapeutic management of hemoglobinopathies and associated outcomes. NRHG may contribute to the formulation of a roadmap for hemoglobinopathies in Europe and promote the implementation of effective public health policies.
Appendix
Available only for authorised users
Literature
3.
go back to reference Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarre C, Beuzard Y, Chretien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M (2018) Gene therapy in patients with transfusion-dependent beta-thalassemia. N Engl J Med 378(16):1479–1493. https://doi.org/10.1056/NEJMoa1705342 CrossRefPubMed Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarre C, Beuzard Y, Chretien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M (2018) Gene therapy in patients with transfusion-dependent beta-thalassemia. N Engl J Med 378(16):1479–1493. https://​doi.​org/​10.​1056/​NEJMoa1705342 CrossRefPubMed
5.
go back to reference Voskaridou E, Ladis V, Kattamis A, Hassapopoulou E, Economou M, Kourakli A, Maragkos K, Kontogianni K, Lafioniatis S, Vrettou E, Koutsouka F, Papadakis A, Mihos A, Eftihiadis E, Farmaki K, Papageorgiou O, Tapaki G, Maili P, Theohari M, Drosou M, Kartasis Z, Aggelaki M, Basileiadi A, Adamopoulos I, Lafiatis I, Galanopoulos A, Xanthopoulidis G, Dimitriadou E, Mprimi A, Stamatopoulou M, Haile ED, Tsironi M, Anastasiadis A, Kalmanti M, Papadopoulou M, Panori E, Dimoxenou P, Tsirka A, Georgakopoulos D, Drandrakis P, Dionisopoulou D, Ntalamaga A, Davros I, Karagiorga M, Greek Haemoglobinopathies Study G (2012) A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births. Ann Hematol 91(9):1451–1458. https://doi.org/10.1007/s00277-012-1465-7 CrossRefPubMed Voskaridou E, Ladis V, Kattamis A, Hassapopoulou E, Economou M, Kourakli A, Maragkos K, Kontogianni K, Lafioniatis S, Vrettou E, Koutsouka F, Papadakis A, Mihos A, Eftihiadis E, Farmaki K, Papageorgiou O, Tapaki G, Maili P, Theohari M, Drosou M, Kartasis Z, Aggelaki M, Basileiadi A, Adamopoulos I, Lafiatis I, Galanopoulos A, Xanthopoulidis G, Dimitriadou E, Mprimi A, Stamatopoulou M, Haile ED, Tsironi M, Anastasiadis A, Kalmanti M, Papadopoulou M, Panori E, Dimoxenou P, Tsirka A, Georgakopoulos D, Drandrakis P, Dionisopoulou D, Ntalamaga A, Davros I, Karagiorga M, Greek Haemoglobinopathies Study G (2012) A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births. Ann Hematol 91(9):1451–1458. https://​doi.​org/​10.​1007/​s00277-012-1465-7 CrossRefPubMed
6.
go back to reference Conte R, Ruggieri L, Gambino A, Bartoloni F, Baiardi P, Bonifazi D, Bonifazi F, Felisi M, Giannuzzi V, Padula R, Pepe A, Putti MC, Del Vecchio GC, Maggio A, Filosa A, Iacono A, Mangiarini L, Ceci A (2016) The Italian multiregional thalassemia registry: centers characteristics, services, and patients’ population. Hematology 21(7):415–424. https://doi.org/10.1080/10245332.2015.1101971 CrossRefPubMed Conte R, Ruggieri L, Gambino A, Bartoloni F, Baiardi P, Bonifazi D, Bonifazi F, Felisi M, Giannuzzi V, Padula R, Pepe A, Putti MC, Del Vecchio GC, Maggio A, Filosa A, Iacono A, Mangiarini L, Ceci A (2016) The Italian multiregional thalassemia registry: centers characteristics, services, and patients’ population. Hematology 21(7):415–424. https://​doi.​org/​10.​1080/​10245332.​2015.​1101971 CrossRefPubMed
7.
go back to reference Thuret I, Pondarre C, Loundou A, Steschenko D, Girot R, Bachir D, Rose C, Barlogis V, Donadieu J, de Montalembert M, Hagege I, Pegourie B, Berger C, Micheau M, Bernaudin F, Leblanc T, Lutz L, Galacteros F, Simeoni MC, Badens C (2010) Complications and treatment of patients with beta-thalassemia in France: results of the National Registry. Haematologica 95(5):724–729. https://doi.org/10.3324/haematol.2009.018051 CrossRefPubMed Thuret I, Pondarre C, Loundou A, Steschenko D, Girot R, Bachir D, Rose C, Barlogis V, Donadieu J, de Montalembert M, Hagege I, Pegourie B, Berger C, Micheau M, Bernaudin F, Leblanc T, Lutz L, Galacteros F, Simeoni MC, Badens C (2010) Complications and treatment of patients with beta-thalassemia in France: results of the National Registry. Haematologica 95(5):724–729. https://​doi.​org/​10.​3324/​haematol.​2009.​018051 CrossRefPubMed
8.
go back to reference Modell B, Khan M, Darlison M, King A, Layton M, Old J, Petrou M, Varnavides L (2001) A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom. Bull World Health Organ 79(11):1006–1013PubMedPubMedCentral Modell B, Khan M, Darlison M, King A, Layton M, Old J, Petrou M, Varnavides L (2001) A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom. Bull World Health Organ 79(11):1006–1013PubMedPubMedCentral
9.
go back to reference Aydinok Y, Oymak Y, Atabay B, Aydogan G, Yesilipek A, Unal S, Kilinc Y, Oflaz B, Akin M, Vergin C, Sezgin Evim M, Caliskan U, Unal S, Bay A, Kazanci E, Ileri T, Atay D, Patiroglu T, Kahraman S, Soker M, Akcan M, Akdeniz A, Buyukavci M, Alanoglu G, Bor O, Soyer N, Ozdemir Karadas N, Uysalol E, Turker M, Akcay A, Ocak S, Gunes AM, Tokgoz H, Unal E, Tiftik N, Karakas Z (2018) A National Registry of Thalassemia in Turkey: demographic and disease characteristics of patients, achievements, and challenges in prevention. Turk J Haematol 35(1):12–18. https://doi.org/10.4274/tjh.2017.0039 CrossRefPubMedPubMedCentral Aydinok Y, Oymak Y, Atabay B, Aydogan G, Yesilipek A, Unal S, Kilinc Y, Oflaz B, Akin M, Vergin C, Sezgin Evim M, Caliskan U, Unal S, Bay A, Kazanci E, Ileri T, Atay D, Patiroglu T, Kahraman S, Soker M, Akcan M, Akdeniz A, Buyukavci M, Alanoglu G, Bor O, Soyer N, Ozdemir Karadas N, Uysalol E, Turker M, Akcay A, Ocak S, Gunes AM, Tokgoz H, Unal E, Tiftik N, Karakas Z (2018) A National Registry of Thalassemia in Turkey: demographic and disease characteristics of patients, achievements, and challenges in prevention. Turk J Haematol 35(1):12–18. https://​doi.​org/​10.​4274/​tjh.​2017.​0039 CrossRefPubMedPubMedCentral
10.
go back to reference Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, Pavlides N, Psiloines M, Simamonian K, Skordos G, Sitarou M, Angastiniotis M (2006) Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica 91(9):1187–1192PubMed Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, Pavlides N, Psiloines M, Simamonian K, Skordos G, Sitarou M, Angastiniotis M (2006) Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica 91(9):1187–1192PubMed
11.
go back to reference Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89(10):1187–1193PubMed Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89(10):1187–1193PubMed
19.
go back to reference Origa R, Danjou F, Cossa S, Matta G, Bina P, Dessi C, Defraia E, Foschini ML, Leoni G, Morittu M, Galanello R (2013) Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major. Br J Haematol 163(3):400–403. https://doi.org/10.1111/bjh.12517 CrossRefPubMed Origa R, Danjou F, Cossa S, Matta G, Bina P, Dessi C, Defraia E, Foschini ML, Leoni G, Morittu M, Galanello R (2013) Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major. Br J Haematol 163(3):400–403. https://​doi.​org/​10.​1111/​bjh.​12517 CrossRefPubMed
23.
go back to reference Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, Salpietro C, Arrigo T (2015) Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment. Eur J Haematol 94(5):404–412. https://doi.org/10.1111/ejh.12444 CrossRefPubMed Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, Salpietro C, Arrigo T (2015) Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment. Eur J Haematol 94(5):404–412. https://​doi.​org/​10.​1111/​ejh.​12444 CrossRefPubMed
32.
go back to reference Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S (1989) Survival and causes of death in thalassaemia major. Lancet 2(8653):27–30CrossRefPubMed Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S (1989) Survival and causes of death in thalassaemia major. Lancet 2(8653):27–30CrossRefPubMed
Metadata
Title
National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality
Authors
Ersi Voskaridou
Antonis Kattamis
Christina Fragodimitri
Alexandra Kourakli
Panagiota Chalkia
Michael Diamantidis
Efthymia Vlachaki
Marouso Drosou
Stilianos Lafioniatis
Konstantinos Maragkos
Fotini Petropoulou
Eftihios Eftihiadis
Marina Economou
Evangelos Klironomos
Freideriki Koutsouka
Konstantina Nestora
Ioanna Tzoumari
Ourania Papageorgiou
Artemis Basileiadi
Ioannis Lafiatis
Efthimia Dimitriadou
Anastasia Kalpaka
Chrysoula Kalkana
Georgios Xanthopoulidis
Ioannis Adamopoulos
Panagiotis Kaiafas
Aikaterini Mpitzioni
Anastasia Goula
Ioannis Kontonis
Chrisoula Alepi
Athanasios Anastasiadis
Margarita Papadopoulou
Polixeni Maili
Dionisia Dionisopoulou
Antigoni Tsirka
Alexandros Makis
Stavroula Kostaridou
Marianna Politou
Ioannis Papassotiriou
on behalf of the Greek Haemoglobinopathies Study Group
Publication date
01-01-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 1/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3493-4

Other articles of this Issue 1/2019

Annals of Hematology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.